{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:48:19Z","timestamp":1760240899385,"version":"build-2065373602"},"reference-count":18,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>We evaluated a protocol comprising intranasal diamorphine (IND) combined with oral short and modified-release morphine for children at the emergency department (ED) with acute painful episodes of sickle cell disease (SCD). In a retrospective audit of 83 episodes in 38 children, the mean time between arrival in the treatment area and the administration of IND was 10 min (range &lt;5 min to 1.39 h). IND was administered in &lt;5 min in 43 (51.6%), and in &lt;20 min in 75 (90.4%) episodes. Persisting pain, requiring background analgesia with modified-release oral morphine, was required in 25 (30.1%) episodes. Inadequate control of pain requiring a switch to intravenous morphine PCA was required in eight episodes in four patients. Acute chest syndrome (ACS) developed in four of 83 episodes (4.8%, 95% CI 0.2\u20139.4%) and in four of 38 children (10.5%, 95% CI 0.7\u201320.5%). In conclusion, this protocol enabled the rapid administration of strong opioid analgesia in an ED setting, and may reduce the short and long-term adverse effects associated with parenteral opioids in children. There was no evidence of an increased incidence of ACS associated with use of oral morphine.<\/jats:p>","DOI":"10.3390\/jcm8101728","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T11:24:15Z","timestamp":1571397855000},"page":"1728","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of a Non-Parenteral Opioid Analgesia Protocol for Acute Sickle Cell Pain Episodes in Children"],"prefix":"10.3390","volume":"8","author":[{"given":"Paul","family":"Telfer","sequence":"first","affiliation":[{"name":"Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London E1 2AT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Barroso","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Royal London Hospital, Bart\u2019s Health NHS Trust, London E1 2ES, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Newell","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Royal London Hospital, Bart\u2019s Health NHS Trust, London E1 2ES, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Challands","sequence":"additional","affiliation":[{"name":"Department of Paediatric Anaesthetics, Royal London Hospital, Bart\u2019s Health NHS Trust, London E1 1BB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Royal London Hospital, Bart\u2019s Health NHS Trust, London E1 2ES, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1553-2712.2007.tb01801.x","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad. Emerg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ajh.24534","article-title":"Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease","volume":"91","author":"Brandow","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/0009922816674521","article-title":"Pain Management for Sickle Cell Disease in the Pediatric Emergency Department: Medications and Hospitalization Trends","volume":"56","author":"Cacciotti","year":"2017","journal-title":"Clin. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pbc.20180","article-title":"Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease","volume":"44","author":"Panepinto","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e4063","DOI":"10.1136\/bmj.e4063","article-title":"Management of an acute painful sickle cell episode in hospital: Summary of NICE guidance","volume":"344","author":"Gillis","year":"2012","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1553-2712.2010.00693.x","article-title":"Adult emergency department patients with sickle cell pain crisis: A learning collaborative model to improve analgesic management","volume":"17","author":"Tanabe","year":"2010","journal-title":"Acad. Emerg. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(97)08462-6","article-title":"Randomised trial of oral morphine for painful episodes of sickle-cell disease in children","volume":"350","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clpt.2003.10.007","article-title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","volume":"75","author":"Kopecky","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmj.322.7281.261","article-title":"Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures","volume":"322","author":"Kendall","year":"2001","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/adc.2008.138875","article-title":"Intranasal diamorphine for acute sickle cell pain","volume":"94","author":"Telfer","year":"2009","journal-title":"Arch. Dis. Child."},{"key":"ref_13","unstructured":"The Royal College of Emergency Medicine (2019, August 25). Management of Pain in Children Best Practice Guideline. Available online: https:\/\/www.rcem.ac.uk\/docs\/RCEMGuidance\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/AJP.0b013e3181bed10c","article-title":"A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic","volume":"26","author":"Lazio","year":"2010","journal-title":"Clin. J. Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","article-title":"A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults","volume":"114","author":"Bartolucci","year":"2009","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","article-title":"Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients","volume":"10","author":"Bartolucci","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: Reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial","volume":"286","author":"Orringer","year":"2001","journal-title":"JAMA"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/10\/1728\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:36Z","timestamp":1760189256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/10\/1728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["jcm8101728"],"URL":"https:\/\/doi.org\/10.3390\/jcm8101728","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2019,10,18]]}}}